Navigation Links
Genetically modified corn affects its symbiotic relationship with non-target soil organisms
Date:4/17/2012

n an agricultural system.

"What makes our study unique is that we evaluated AMF colonization in 14 different lines of Bt and non-Bt corn under consistent experimental conditions in a greenhouse using locally collected agricultural field soil as the AMF inoculum," said Cheeke.

"The use of whole soil in this study allowed each Bt and non-Bt corn line to interact with a community of soil organisms, making this study more ecologically relevant than other greenhouse studies that use a single species of AMF," she adds.

Interestingly, the authors found that colonization of plant roots by symbiotic soil fungi was lower in the genetically modified Bt corn than in the control lines. However, there was no difference in root biomass or shoot biomass between the two types of corn at the time of harvest.

Cheeke and co-authors also determined that the Bt-protein itself is not directly toxic to the fungi since AMF colonization of vegetable soybeans did not differ for those grown in soil previously containing Bt vs. non-Bt corn.

Together these findings contribute to the growing body of knowledge examining the unanticipated effects of Bt crop cultivation on non-target soil organisms. Examining non-target effects of genetically engineered crops on symbiotic soil organisms becomes even more important as acreage devoted to the cultivation of Bt crops continues to increase globally.

"In 2011, 88% of the corn cultivated in the United States was genetically modified to express insect resistance, herbicide tolerance, or some combination of stacked traits," Cheeke commented. "Globally, genetically modified corn is cultivated in at least 16 different countries."

Cheeke notes that the next step is to understand the ecological significance of this study. "In greenhouse studies Bt corn had lower levels AMF colonization, so now it is important to see i
'/>"/>

Contact: Richard Hund
rhund@botany.org
314-577-9557
American Journal of Botany
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. New genetically engineered mice aid understanding of incurable neuromuscular disease
2. Cleveland Clinic Childrens Hospital launches study to genetically test for autism
3. Scientists refute Greenpeace claim that genetically modified corn caused new insect pest
4. Cleft lip corrected genetically in mouse model
5. Iowa State University scientists genetically increase algae biomass by more than 50 percent
6. New American Chemical Society podcast: Genetically-engineered spider silk for gene therapy
7. The establishment of genetically engineered canola populations in the US
8. University of Colorado Cancer Center genetically sequences most common bladder cancer
9. Genetically engineered spider silk for gene therapy
10. Scientist urges government ruling on genetically engineered salmon
11. AgriLife Research genetically fingerprinting E. coli from watersheds
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Genetically modified corn affects its symbiotic relationship with non-target soil organisms
(Date:8/25/2015)... BELLEVUE, Wash. , Aug. 25, 2015 /PRNewswire/ ... announced today it will unveil its "Guardian S" snake ... the National Tactical Officers Association Conference on August 30 ... S is the first-ever commercially available energetically autonomous snake ... and in-field trials and is protected by more than ...
(Date:8/20/2015)... 2015 The wearable technology market has ... and healthy. However, wearable technology has the potential ... help improve diagnostic capabilities and therapeutic outcomes. Today, ... Wearable Technologies Conference 2015 , where Barrett ... in healthcare.    "Over the past ...
(Date:8/19/2015)... HAUPPAUGE, N.Y. , Aug. 19, 2015 /PRNewswire/ ... announced that it has entered into a Definitive ... intellectual property, of iris authentication market leader EyeLock ... transaction, VOXX will have a controlling interest in ... is subject to completion of due diligence.  Expanding ...
Breaking Biology News(10 mins):Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 2VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 3VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 4VOXX International Corporation Signs Definitive Agreement To Acquire The Assets And A Controlling Interest Of Biometric Leader EyeLock 5
... Hole Research Center are analyzing the surprising results of the ... rainforest. , From January 2000 to July 2004, rainfall was ... of the Tapajós National Forest, in Brazil. A total of ... by 6' clear plastic panels suspended 3 to 12 feet ...
... Affymetrix Inc. (Nasdaq: AFFX - News) and Karolinska ... a strategic alliance designed to improve healthcare by ... tools for better diagnosis, prognosis, and treatment. , ... genetic analyses and measurement of gene expression in ...
... have discovered an important chemical in the brain's ... symptoms of opioid drugs like morphine and heroin. ... chemical--called a transporter--could relieve some of the early ... shaking, and jumpiness. Such drugs could become part ...
Cached Biology News:World's largest rainforest drying experiment completes first phase 2World's largest rainforest drying experiment completes first phase 3Affymetrix and the Karolinska Institutet Announce Translational Medicine Strategic Alliance 2Affymetrix and the Karolinska Institutet Announce Translational Medicine Strategic Alliance 3Key Trigger Of Opioid Withdrawal Symptoms Found 2
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... In her ... expertly transports the reader to a not-so-distant future faced with an Ebola pandemic that ... professional who overcomes personal tragedy to enter the world of counterterrorism, and who continues ...
(Date:9/1/2015)... ... ... Knowledgent , the data and analytics firm, today announced a new ... the healthcare industry. , As the Internet of Things (IoT) continues to grab headlines ... years as more entities become technology enabled through Electronic Medical Records (EMRs). , With ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... of a groundbreaking new version of its flagship DNA design platform, which has ... complex DNA sequences into numerous genetic parts, which in turn can be recombined ...
(Date:8/31/2015)... , Aug. 31, 2015 MabVax Therapeutics ... company announces that the Company,s lead antibody, HuMab 5B1, ... five separate presentations during the upcoming World Molecular Imaging ... September 2-5, 2015. Researchers from the Department of ... present results on the use of MabVax,s lead antibody ...
Breaking Biology Technology:Alexi Venice’s Debut Novel Takes on the Human Testing of a Vaccine for Ebola and Revenge by an Anti-Big Pharma Terrorist Group in ‘Ebola Vaccine Wars' 2Alexi Venice’s Debut Novel Takes on the Human Testing of a Vaccine for Ebola and Revenge by an Anti-Big Pharma Terrorist Group in ‘Ebola Vaccine Wars' 3New White Paper Explores Data Lake Opportunities in the Healthcare Industry 2GenoCAD Releases Combinatorial Design Tool to Optimize Protein Expression and Streamline DNA Synthesis Orders 2MabVax Therapeutics HuMab 5B1 Antibody Is Highlighted at Upcoming World Molecular Imaging Congress in Five Separate Presentations 2MabVax Therapeutics HuMab 5B1 Antibody Is Highlighted at Upcoming World Molecular Imaging Congress in Five Separate Presentations 3MabVax Therapeutics HuMab 5B1 Antibody Is Highlighted at Upcoming World Molecular Imaging Congress in Five Separate Presentations 4
... Brain Metastases, PALO ALTO, Calif., Sept. 2 ... radiosurgery treatments for,multiple brain metastases using new RapidArc ... ). The MIMA Cancer Center in Melbourne,Florida and ... able to treat brain metastases more quickly and ...
... BMRN ) today announced that Jean-Jacques,Bienaime, Chief Executive ... 3rd Annual Citi Biotech Day in New York City ... Interested parties may access a live audio webcast of ... website, http://www.BMRN.com .,A replay of the call will ...
... development milestone payment to InterMune - ... to lead ITMN-191 program in Phase 2 -, BRISBANE, ... announced that InterMune has earned a $15 million,development milestone under ... NS3 protease inhibitor compound ITMN-191,(referred to as R7227 at Roche), ...
Cached Biology Technology:Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems 2Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems 3Brain Cancer Patients at Two Leading Hospitals Treated Using Fast and Efficient RapidArc Radiotherapy Technology from Varian Medical Systems 4BioMarin to Present at the Citi Biotech Day 2InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche 2InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche 3InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche 4